Blogs

What Are the Implications of MDR for Software as a Medical Device (SaMD)?

Blogs /

1. Introduction: What is SaMD? Definition of SaMD Software as a Medical Device (SaMD) refers to software that is intended to perform medical functions without being part of a hardware medical device. It operates independently of any physical device, meaning it does not require embedded systems in medical hardware to serve its purpose. SaMD may […]

What Are the Implications of MDR for Software as a Medical Device (SaMD)? Read More »

How Should Manufacturers Handle Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) Obligations Effectively Under EU MDR?

Blogs /

Background: Why PMS & PMCF are Game-Changers under EU MDR Regulatory Evolution: From MDD to MDR Under the previous Medical Device Directive (MDD 93/42/EEC), Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) were vaguely defined and often implemented passively. Manufacturers generally conducted PMS reactively—primarily investigating complaints or adverse events without a proactive approach to data

How Should Manufacturers Handle Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) Obligations Effectively Under EU MDR? Read More »

How Can Small and Medium Enterprises (SMEs) Survive Under MDR’s Regulatory Burden?

Blogs /

Background Context The EU Medical Device Regulation (MDR 2017/745) came into force in May 2021 (with transition timelines extended to 2028/2029 in some cases via Regulation (EU) 2023/607). It introduced stricter requirements for clinical evidence, post-market surveillance, quality management, traceability, and technical documentation compared to the previous Medical Device Directive (MDD 93/42/EEC). For Small and

How Can Small and Medium Enterprises (SMEs) Survive Under MDR’s Regulatory Burden? Read More »

error: Content is protected !!